a Phase 2 study of DISC-0974 in anemia of myelofibrosis (MF)
Latest Information Update: 18 Nov 2024
Price :
$35 *
At a glance
- Drugs DISC 0974 (Primary)
- Indications Anaemia; Myelofibrosis
- Focus Therapeutic Use
- 18 Nov 2024 New trial record
- 12 Nov 2024 According to the Disc Medicine Media Release, company expects to initiate this Phase 2 study in anemia of myelofibrosis (MF) by the end of 2024